2016 Jul 16
Novel testing approaches better equip physicians to identify myeloma risks
Adriana Rossi, M.D., discusses how physicians are becoming better equipped to detect monoclonal gammopathy of undetermined significance, which may help identify patients at risk for myeloma. Read more


















